We serve Chemical Name:5-Fluoro-2-(1H-pyrazol-1-yl)benzaldehyde CAS:1015845-84-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Fluoro-2-(1H-pyrazol-1-yl)benzaldehyde
CAS.NO:1015845-84-7
Synonyms:5-fluoro-2-pyrazol-1-ylbenzaldehyde
Molecular Formula:C10H7FN2O
Molecular Weight:190.17400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:34.89000
Exact Mass:190.05400
LogP:1.82390
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 5-fluoro-2-pyrazol-1-ylbenzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-fluoro-2-pyrazol-1-ylbenzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-fluoro-2-pyrazol-1-ylbenzaldehyde Use and application,5-fluoro-2-pyrazol-1-ylbenzaldehyde technical grade,usp/ep/jp grade.
Related News: If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role. 5-Fluoro-2-(1H-pyrazol-1-yl)benzaldehyde manufacturer If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role. 5-Fluoro-2-(1H-pyrazol-1-yl)benzaldehyde supplier Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs. 5-Fluoro-2-(1H-pyrazol-1-yl)benzaldehyde vendor This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 5-Fluoro-2-(1H-pyrazol-1-yl)benzaldehyde factory This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement.
